tadalafil has been researched along with thiourea in 1 studies
Studies (tadalafil) | Trials (tadalafil) | Recent Studies (post-2010) (tadalafil) | Studies (thiourea) | Trials (thiourea) | Recent Studies (post-2010) (thiourea) |
---|---|---|---|---|---|
1,742 | 392 | 1,089 | 6,959 | 46 | 1,737 |
Protein | Taxonomy | tadalafil (IC50) | thiourea (IC50) |
---|---|---|---|
Urease | Canavalia ensiformis (jack bean) | 0.56 | |
Serine-protein kinase ATM | Homo sapiens (human) | 0.2 | |
Serine/threonine-protein kinase ATR | Homo sapiens (human) | 0.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frankenreiter, S; Friebe, A; Groneberg, D; Krieg, T; Kuret, A; Lukowski, R; Ruth, P | 1 |
1 other study(ies) available for tadalafil and thiourea
Article | Year |
---|---|
Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
Topics: Animals; Benzoates; Cyclic GMP; Disease Models, Animal; Enzyme Activators; Female; Ischemic Postconditioning; Large-Conductance Calcium-Activated Potassium Channels; Male; Mice, Knockout; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Signal Transduction; Sildenafil Citrate; Soluble Guanylyl Cyclase; Tadalafil; Tetrazoles; Thiourea; Time Factors; Up-Regulation | 2018 |